Description Module
The Description Module contains narrative descriptions of the clinical trial, including a brief summary and detailed description. These descriptions provide important information about the study's purpose, methodology, and key details in language accessible to both researchers and the general public.
Description Module path is as follows:
Study -> Protocol Section -> Description Module
Description Module
Ignite Creation Date:
2025-12-24 @ 10:34 PM
Ignite Modification Date:
2025-12-24 @ 10:34 PM
NCT ID:
NCT06254235
Brief Summary:
The goal of this clinical trial is to evaluate the pharmacokinetic characteristics of two octreotide microsphere formulations in healthy Chinese volunteers.
Participants will receive single-dose of either test or reference octreotide microsphere formulations.
Researchers will compare pharmacokinetic characteristics of the two formulations to see if they are bioequivalent.
Study:
NCT06254235
Study Brief:
Protocol Section:
NCT06254235